GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001000111 | Oral cavity | LP | glial cell differentiation | 78/4623 | 225/18723 | 4.82e-04 | 4.52e-03 | 78 |
GO:003361913 | Oral cavity | LP | membrane protein proteolysis | 25/4623 | 57/18723 | 1.19e-03 | 9.62e-03 | 25 |
GO:004298211 | Oral cavity | LP | amyloid precursor protein metabolic process | 37/4623 | 95/18723 | 1.45e-03 | 1.14e-02 | 37 |
GO:003361921 | Oral cavity | EOLP | membrane protein proteolysis | 16/2218 | 57/18723 | 7.07e-04 | 5.78e-03 | 16 |
GO:000650912 | Oral cavity | EOLP | membrane protein ectodomain proteolysis | 13/2218 | 43/18723 | 1.03e-03 | 7.63e-03 | 13 |
GO:004259317 | Oral cavity | EOLP | glucose homeostasis | 46/2218 | 258/18723 | 2.96e-03 | 1.74e-02 | 46 |
GO:003350017 | Oral cavity | EOLP | carbohydrate homeostasis | 46/2218 | 259/18723 | 3.20e-03 | 1.86e-02 | 46 |
GO:005160423 | Oral cavity | EOLP | protein maturation | 50/2218 | 294/18723 | 5.32e-03 | 2.77e-02 | 50 |
GO:000650921 | Oral cavity | NEOLP | membrane protein ectodomain proteolysis | 15/2005 | 43/18723 | 2.17e-05 | 3.57e-04 | 15 |
GO:003361931 | Oral cavity | NEOLP | membrane protein proteolysis | 17/2005 | 57/18723 | 6.31e-05 | 8.33e-04 | 17 |
GO:005160432 | Oral cavity | NEOLP | protein maturation | 50/2005 | 294/18723 | 6.46e-04 | 5.47e-03 | 50 |
GO:001648521 | Oral cavity | NEOLP | protein processing | 39/2005 | 225/18723 | 1.68e-03 | 1.17e-02 | 39 |
GO:00429822 | Oral cavity | NEOLP | amyloid precursor protein metabolic process | 20/2005 | 95/18723 | 2.28e-03 | 1.47e-02 | 20 |
GO:0016486 | Oral cavity | NEOLP | peptide hormone processing | 8/2005 | 24/18723 | 2.59e-03 | 1.63e-02 | 8 |
GO:0140448 | Oral cavity | NEOLP | signaling receptor ligand precursor processing | 8/2005 | 25/18723 | 3.46e-03 | 2.05e-02 | 8 |
GO:00487083 | Oral cavity | NEOLP | astrocyte differentiation | 17/2005 | 81/18723 | 4.85e-03 | 2.64e-02 | 17 |
GO:004206321 | Oral cavity | NEOLP | gliogenesis | 47/2005 | 301/18723 | 5.26e-03 | 2.82e-02 | 47 |
GO:001000121 | Oral cavity | NEOLP | glial cell differentiation | 37/2005 | 225/18723 | 5.38e-03 | 2.88e-02 | 37 |
GO:004259324 | Oral cavity | NEOLP | glucose homeostasis | 40/2005 | 258/18723 | 1.06e-02 | 4.93e-02 | 40 |
GO:00516049 | Prostate | BPH | protein maturation | 80/3107 | 294/18723 | 2.64e-06 | 4.23e-05 | 80 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ACE2 | SNV | Missense_Mutation | novel | c.1216G>A | p.Glu406Lys | p.E406K | Q9BYF1 | protein_coding | deleterious(0.01) | probably_damaging(0.98) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ACE2 | SNV | Missense_Mutation | | c.484N>T | p.Leu162Phe | p.L162F | Q9BYF1 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-D8-A1JG-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
ACE2 | insertion | Nonsense_Mutation | novel | c.1544_1545insCTATTGATTGCTGATGACGGGGACAAGATC | p.Tyr516_Thr517insTer | p.Y516_T517ins* | Q9BYF1 | protein_coding | | | TCGA-AO-A128-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
ACE2 | SNV | Missense_Mutation | novel | c.1854C>G | p.Ile618Met | p.I618M | Q9BYF1 | protein_coding | deleterious(0) | probably_damaging(0.985) | TCGA-EK-A2RN-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
ACE2 | SNV | Missense_Mutation | novel | c.1371N>C | p.Glu457Asp | p.E457D | Q9BYF1 | protein_coding | tolerated(1) | possibly_damaging(0.536) | TCGA-HM-A4S6-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
ACE2 | SNV | Missense_Mutation | novel | c.2408C>T | p.Thr803Ile | p.T803I | Q9BYF1 | protein_coding | deleterious_low_confidence(0) | benign(0.388) | TCGA-VS-A958-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
ACE2 | SNV | Missense_Mutation | novel | c.1486A>G | p.Thr496Ala | p.T496A | Q9BYF1 | protein_coding | tolerated(0.24) | benign(0.005) | TCGA-ZJ-AB0H-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD |
ACE2 | SNV | Missense_Mutation | novel | c.1091N>C | p.Val364Ala | p.V364A | Q9BYF1 | protein_coding | deleterious(0) | possibly_damaging(0.502) | TCGA-AA-3947-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ACE2 | SNV | Missense_Mutation | novel | c.2269A>G | p.Ile757Val | p.I757V | Q9BYF1 | protein_coding | tolerated_low_confidence(0.58) | benign(0.01) | TCGA-AA-3950-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ACE2 | SNV | Missense_Mutation | rs865959788 | c.1010N>A | p.Gly337Glu | p.G337E | Q9BYF1 | protein_coding | tolerated(0.43) | benign(0.023) | TCGA-AA-3977-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
59272 | ACE2 | ENZYME, TRANSPORTER, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, CELL SURFACE, PROTEASE | inhibitor | 223366196 | ORE-1001 | |
59272 | ACE2 | ENZYME, TRANSPORTER, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, CELL SURFACE, PROTEASE | | GL1001 | ORE-1001 | |
59272 | ACE2 | ENZYME, TRANSPORTER, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, CELL SURFACE, PROTEASE | | GSK2586881 | GSK-2586881 | 25893478 |
59272 | ACE2 | ENZYME, TRANSPORTER, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, CELL SURFACE, PROTEASE | | ORE-1001 | ORE-1001 | |
59272 | ACE2 | ENZYME, TRANSPORTER, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, CELL SURFACE, PROTEASE | inhibitor | 178103169 | | |
59272 | ACE2 | ENZYME, TRANSPORTER, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, CELL SURFACE, PROTEASE | activator | 223366197 | | |
59272 | ACE2 | ENZYME, TRANSPORTER, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, CELL SURFACE, PROTEASE | | LISINOPRIL | LISINOPRIL | |
59272 | ACE2 | ENZYME, TRANSPORTER, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, CELL SURFACE, PROTEASE | | 178101824 | | |
59272 | ACE2 | ENZYME, TRANSPORTER, DRUGGABLE GENOME, NEUTRAL ZINC METALLOPEPTIDASE, CELL SURFACE, PROTEASE | | captopril | CAPTOPRIL | 17473847 |